)

TScan Therapeutics (TCRX) investor relations material
TScan Therapeutics H.C. Wainwright 27th Annual Global Investment Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Key clinical program updates
Lead heme malignancy program showed an 8% relapse rate in treated patients versus 33% in controls, prompting advancement to a pivotal trial this year.
Updated phase one data and longer-term follow-up will be presented at a major medical conference at year-end.
Pivotal trial will use TSC-101, with a synthetic control arm from the CIBMTR database, aiming for top-line data by end of 2027.
Expansion to additional HLA types is underway, with two new TCRs in IND-enabling activities and more in discovery.
$218 million in cash provides runway into Q1 2027.
Clinical data and safety
Phase one study included 26 treated and 12 control patients, with balanced high-risk profiles between arms.
Treatment was well tolerated, with no increase in adverse events compared to controls; only mild, manageable CRS observed.
Treated patients showed higher rates of complete donor chimerism and sustained MRD negativity post-infusion.
Substantial reduction in relapse rates observed, supporting progression to pivotal trial.
Market opportunity and expansion
Initial addressable market is ~1,300 patients/year in the US and Europe, with potential to expand to over 5,000 as clinical practice shifts.
Expansion to additional HLA types could double the market, with further opportunities to reach over 15,000 patients annually.
Next TScan Therapeutics earnings date

Next TScan Therapeutics earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage